NEUROPACE
Updates & Highlights
NPCE Explains How NeuroPace's RNS System Makes Money
NPCE Explains How NeuroPace's RNS System Makes Money
MSN · 6 days ago
NPCE - Neuropace Inc. stock news, filings & ratings
NPCE - Neuropace Inc. stock news, filings & ratings
Quantisnow · 8 days ago
NeuroPace receives FDA approval for AI-driven ECoG Assistant
NeuroPace receives FDA approval for AI-driven ECoG Assistant
Investing.com · 8 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at NeuroPace?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentNPCE Explains How NeuroPace's RNS System Makes Money
NPCE Explains How NeuroPace's RNS System Makes Money
MSN · 6 days ago
NPCE - Neuropace Inc. stock news, filings & ratings
NPCE - Neuropace Inc. stock news, filings & ratings
Quantisnow · 8 days ago
NeuroPace receives FDA approval for AI-driven ECoG Assistant
NeuroPace receives FDA approval for AI-driven ECoG Assistant
Investing.com · 8 days ago
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
Business Wire · 8 days ago
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Yahoo Finance · 8 days ago
NeuroPace Inc (NPCE) CEO covers tax bill through share withholding
NeuroPace Inc (NPCE) CEO covers tax bill through share withholding
Stock Titan · 9 days ago
NeuroPace (NPCE) CMO has 358 shares withheld to cover RSU taxes
NeuroPace (NPCE) CMO has 358 shares withheld to cover RSU taxes
Stock Titan · 9 days ago
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
Zacks Investment Research · 10 days ago
NeuroPace (NPCE) Q1 2026 Earnings Transcript
NeuroPace (NPCE) Q1 2026 Earnings Transcript
AOL.com · 16 days ago
NeuroPace (NPCE) up 0.9% since last earnings report: Can it continue?
NeuroPace (NPCE) up 0.9% since last earnings report: Can it continue?
MSN · 17 days ago
NeuroPace (NPCE) CMO receives new RSU and stock option awards
NeuroPace (NPCE) CMO receives new RSU and stock option awards
Stock Titan · 18 days ago
NeuroPace (NPCE) CEO receives new RSU and stock option awards
NeuroPace (NPCE) CEO receives new RSU and stock option awards
Stock Titan · 18 days ago
NeuroPace (NPCE) CFO receives RSU and stock option awards in Form 4 filing
NeuroPace (NPCE) CFO receives RSU and stock option awards in Form 4 filing
Stock Titan · 18 days ago
H.C. Wainwright raises NeuroPace stock price target to $20 on guidance
H.C. Wainwright raises NeuroPace stock price target to $20 on guidance
Investing.com · 19 days ago
OrbiMed reports 2,096,527 shares (6.2%) in NeuroPace (NPCE)
OrbiMed reports 2,096,527 shares (6.2%) in NeuroPace (NPCE)
Stock Titan · 22 days ago
Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $19
Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $19
Moomoo · 22 days ago
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
simplywall.st · 22 days ago
Here's why you should add NeuroPace stock to your portfolio now
Here's why you should add NeuroPace stock to your portfolio now
MSN · 23 days ago
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Yahoo Finance · 23 days ago
NeuroPace (NPCE) Q1 Loss Near US$6.7 Million Tests Bullish Profitability Narratives
NeuroPace (NPCE) Q1 Loss Near US$6.7 Million Tests Bullish Profitability Narratives
simplywall.st · 23 days ago